Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition

NCT00004697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-03-25

No results posted yet for this study

Summary

OBJECTIVES:

I. Determine whether intravenous choline supplementation will reverse the hepatic steatosis and improve liver function in patients who receive long term total parenteral nutrition.

Conditions

Interventions

DRUG

choline chloride

Sponsors & Collaborators

  • University of Texas

    lead OTHER

Principal Investigators

  • Alan Lewis Buchman · University of Texas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
16 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-11-30
Completion
1999-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004697 on ClinicalTrials.gov